Global Stem Cell Group Celebrates Success of ISSCA World Congress
The International Society of Stem Cell Applications (ISSCA) held its first World Congress on Regenerative Medicine at the Radisson Blu Hotel in Istanbul, Turkey between the 23rd and 26th of September, 2022. Like the previous events, the Congress brought together world-class physicians and scientists from over 35 countries, giving medical professionals access to first-rate live discussions, educational sessions, and intensive hands-on experience on regenerative medicine, cellular therapies, and all crucial topics in between.
Recognition Awards Were Presented
Announced in August 2022, the event was an immense success as it only spanned its prescheduled dates and had programs proceed accordingly. It featured an opening address from the President himself, Dr. Daeyong Kim, Ph.D., through which he recognized Mr. Salim Yildrim and Mr. Benito Novas with awards for their contribution to training and seminars held during the Covid-19 Pandemic. He also announced them as the hosts of the event.
The event was conducted at the Radisson Blu Hotel in Istanbul, Turkey. Including convenient breaks in between, its programs were split into 30 theoretical lectures for the first two days and two exclusive practice sessions on the third and fourth days.
With the Covid-19 pandemic further emphasizing the need for faster deployment of medical technologies, the theoretical lectures on the 23rd of September started with why and when Mesenchymal Stem Cells should be used for treatments.
On the first day, lectures featuring a progressive series of topics that define regenerative medicine were given. These included talks on:
- Clinical preconditioning for stem cells application;
- Stem cell and immunomodulation;
- The New era of regenerative medicine exosomes in clinical applications; and
- Plastic and reconstructive surgery guidelines and protocols for regenerative medicine & stem cell application.
Attendees were educated on cellular therapy on the second day, with speakers talking extensively on topics such as:
- Car-T cell therapy;
- Stem cell applications in ophthalmology;
- Ovarian regeneration: Treatment of female infertility using cellular therapies;
- Stem Cell therapy in systemic cardiomyopathy & heart failure; and
- The Multidisciplinary approach to ozone therapy.
At the close, both days accommodated additional abstract lectures from Dr. Serdar Kabataş, Dr. Erdinç Civelek, Dr. Erek Öztürk, and Dr. Eyüp Can Savrunlu. Although for attendees that opted for the two-day Conference package, the event had come to an end, they wouldn’t go home just yet.
A Sumptuous Gala Dinner Was Held
Everyone was treated to a gala dinner at the Old City Hotel at 360 Meze, Seres, Istanbul. This was a chance to meet the lecturers, physicians, and scientists in a less classroom-like environment and served as the perfect opportunity for networking and medical community building, just as the announcement promised.
The third day then welcomed members of the full-access program to a one-day hands-on training session held at the ReGen iC clinic.
Our program bestowed attendees with certificates of participation and membership, with training workshops championed by three ISSCA-certified physicians: Maritza Novas, the Director of Research and Development at Global Stem Cells Group, Miami, USA, Dr. Melihcan Sezgic, Regenerative Medicine Specialist and Surgeon, and Dr. Hilmi Karadeni̇z, Orthopedic doctor and specialist in sports medicine.
Open to only licensed physicians, practicals then concentrated on aesthetic and clinical applications of stem cell therapy. This included processes on cellular products, production, manufacturing and quality control, protocol discussion, and the application of protocols in live patients.
To cap it all off, Benito Novas, our Vice President and one of the awards recipients expressed his joy at the success of the ISSCA World Congress. He said, “It has been great meeting with worldclass doctors and scientists from different countries and having access to extensive practical experience in regenerative medicine and cellular therapies. You have all been generous in sharing your knowledge and experience in Regenerative Medicine. Truly, you have made this first ISSCA World Congress a success.”
The ISSCA successfully built on its bounce back events after a break caused by the pandemic. This was by presenting medical professionals globally with breakthrough updates on technologies, brands, and products for stem cell therapy, tissue engineering, and regenerative medicine in general. To learn more about the ISSCA, please visit https://www.issca.us/ or email us at info@stemcellsgroup.com.
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
Announcement of Training in Fort Lauderdale, Florida by The Global Stem Cells Group
Recently, the Global Stem Cells Group announced plans to teach physicians the value and process behind incorporating regenerative medicine into their own clinical practices. MIAMI, 4–5 November 2022—Global Stem Cells Group, a multidisciplinary community of scientists and physicians that are working together to cure diseases and relieve human pain through the advancement of the field of regenerative medicine, announced today a plan of training in Fort Lauderdale on November 4th and 5th. This training aims to equip physicians with the value and knowledge behind incorporating regenerative medicine into their own clinical practice. Benito Novas, CEO of GSCG, is confident that the event will bring together a group of:
- Doctors are seeking training, products, and equipment in regenerative medicine.
- Doctors who care for patients with conditions that can be treated with cell therapies
- Aesthetic doctors.
- Doctors who want to be up to date with the latest technologies and protocols
- Doctors with an interest in new research on stem cells, MSC, Exosomes, and medical networks want to attract more clients.
The training course is intended to cover:
- Hands-On portion: Doctors, in a controlled environment and guided by a team of medical professionals, will have the opportunity to see procedures being performed a few feet away and then get the opportunity to try them for themselves.
- Review of stem cell biology
- Characterization of cells, cell products, cytokines, and growth factors, as well as their capacity for regeneration.
- Laboratory Processes
- Clinical applications
- Product validation
- Practice Management
- Patient acquisition
The International Society for Stem Cell Application (ISSCA) has done intensive research on this topic and the team will take a lead in educating, training, and certification during the event. As a medical speciality, regenerative standards and certification are very important, which is why ISSCA will provide certificates after the training. By the end of the training course, you will understand everything you need to know to add adult stem cellbased procedures to your existing practice. As before, the united efforts of the seven major medical corporations will provide practitioners with a one-stop hub for stem cell solutions that adhere to the highest medical standards. To find more about the courses and to make reservations for this particular event, head on to their website www.issca.us/autologous-miami-november/ .us email info@stemcellsgroup.com or dial +1305 560 5337.
About ISSCA
ISSCA is a multidisciplinary community that brings together scientists and physicians, all of whom aspire to treat diseases and relieve human pain through advances in science, technology, and the practice of regenerative medicine. ISSCA serves its members through innovations made to the speciality of regenerative medicine. The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, training, research, education, and certification.
As a medical speciality, regenerative medicine standards and certifications are very important, which is why ISSCA provides certification training globally. This is because they want to encourage more physicians to practice regenerative medicine and make it accessible to benefit patients both nationally and worldwide. Incorporated under the Republic of Korea as a nonprofit entity, the ISSCA’s main goal is to promote excellence and standards in the field of regenerative medicine. As a physician, missing this chance to book a personalized hands-on training session must cost you dearly. Contact + 1 305 560 5337 to book as early as possible.
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
GSCG announces an on-site course at OHIO
Global Stem Cells Group (GSCG) has announced a new on-site training course to be conducted through the International Society for Stem Cell Application (ISSCA) in Ohio. This on-site training course will be presented as a total solution to teach and train medical practitioners on the most recent advances in cellular-based treatments and regenerative medicine. It demonstrates the growing demand for clinics and doctors to integrate regenerative medicine into their services.
Personalized Hands-On Training with Industry-Leading Instructors
The new on-site training course to be conducted in Ohio will offer a personalized, hands-on approach, bringing industry leading instructors to the trainees’ clinics. “This course takes a highly visual and interactive angle, which provides trainers with the ability to teach reintegration and procedural techniques on live patients using different protocols for isolating stem cells – right from their own medical establishment,” says Benito Novas, CEO of the GSCG.
The on-site training course will include and offer the following:
Fully Dedicated Instructors
The hands-on approach to this training course involves using industry-leading instructors to offer one-on-one learning. It is the best and most effective way of learning, understanding, and becoming skilled at adipose stem cells and bone marrow extraction procedures.
Staff Training
Doctors usually delegate the process of PRP isolation and obtaining stem cells from bone marrow or fat to their nurses and medical assistants because the procedures are methodical. However, nurses and medical assistants must be fully trained and skilled in these fields. This course imparts them with the relevant skills, enabling them to perform these procedures when doctors need their help.
Trainees’ Preferred Treatment Protocols
This will be a personalized training course, so trainees can choose the treatment protocols they want to learn about and the illnesses they want to target. The instructors will teach not only the process of obtaining cells; they will also reintegrate the cells into the patient and teach about the various reintegration methods based on the patient’s medical conditions.
Equipment & Kits
Isolating and reintegrating stem cells requires the use of certain equipment and kits. The administrators will deliver and install the required equipment, kit, and consumables in the trainees’ clinics.
The Scheduling Process
This course is fully personalized, meaning trainees will have varying needs and preferences. The ISSCA will conduct an initial consultation to discuss the types of treatments trainees want to learn, the patients they need to schedule for treatment, and the underlying costs. The information provided during the initial consultation will enable the ISSCA to gather the relevant supplies, equipment, and training materials for each training session.
About Global Stem Cell Group (GSCG)
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About the International Society for Stem Cell Application (ISSCA)
ISSCA is a multidisciplinary community of physicians and scientists working together to advance science, technology, and the practice of regenerative medicine to treat diseases and lessen human suffering. The group aims to assume a leadership position in regenerative medicine’s research, publication, education, training, and certification standards. ISSCA adopts a hands-on approach by offering certification training worldwide, spreading the practice of regenerative medicine.
- Published in News
Announcement Of Additional Training Days For Cell therapy Certification in Cancún
The International Society for Stem Cell Application (ISSCA) announced that it would conduct a regenerative medicine certification training course in stem cell therapy in Cancun, Mexico, from 7th to 8th October. Now, the ISSCA is thrilled to announce that the original training course has been sold out. Those still interested in taking this stem cell therapy course will also be glad to know that the ISSCA has scheduled a new opening date: from 9th to 10th October.
This announcement is driven by the growing demand for doctors in Mexico to learn and include stem cell therapy in their services. “We are excited to learn that our upcoming course on cell therapy in Cancun, Mexico has sold out, which shows that more and more physicians want to implement regenerative medicine in their clinics,” says Benito Novas, Founder and CEO of Global Stem Cells Group (GSCG). ISSCA is an educational division of GSCG.
New Opening Date, Same Training Course
There is a new date open to doctors who were not able to register on the original date..The skills and lessons taught remain the same, giving trainees in the second shift access to the same knowledge as those in the original shift.
This two-day course will teach how to harvest bone marrow and adipose stem cells from patients in a clinical setting. It is designed for physicians and high-level practitioners.
The first day will cover the course’s theoretical portion, familiarizing the doctors with the subject. The second day will then cover the course’s practical portion using live cases of various clinical applications of stem cells and exosomes in a clinical setting.
Doctors will learn skills to help them treat their patients more effectively. These skills will also help advance their careers, especially considering the growing importance of stem cell therapy across multiple medical fields. The course will only be available for eight people, so time is of the essence for those who wish to book a spot. Visit https://cursocelulasmadre.com/cursosde-certificacion/cursos-presenciales/ to learn more about the course and register.
About the Global Stem Cells Group (GSCG)
GSCG is a global network of seven major medical corporations exploring various ways of advancing technological and scientific advancements in stem cell development, treatment, and training.
The advancements achieved by GSCG enable it to provide medical practitioners with stem cell solutions that are compliant with the highest medical standards. The company is also publicly traded under the symbol MSSV.
About the International Society for Stem Cell Application (ISSCA)
ISSCA is the educational division of GSCG. It is also a multidisciplinary group of scientists and physicians exploring various ways of advancing the technology, science, and practice of regenerative medicine. The group aims to assume a leadership position in regenerative medicine’s research, publication, education, training, and certification standards. ISSCA has trained more than 10,000 physicians worldwide and adopts a hands-on approach by offering certification training worldwide, spreading the practice of regenerative medicine. Their main goal is to treat diseases more effectively, thereby reducing human suffering.
- Published in News
Global Stem Cells Group Announces the Launch of a New Bone Marrow Harvesting Kit
The Global Stem Cells Group has announced the launch of a new bone marrow harvesting kit in response to a request for effective and accessible solutions to regenerative medicine procedures
Bone marrow is a spongy tissue that is located inside most large bones – it is essential for generating red blood cells (erythrocytes), white blood cells (leukocytes) and platelets (thrombocytes), using a bone marrow aspirate needle to collect the aspirate can help physicians perform different regenerative treatments especially in osteomioarticular conditions.
Increased Stem and Progenitor Cell Concentrations in Marrow Aspiration
According to the company, the new kit for processing and extraction of pure bone marrow has demonstrated its ability to increase stem and progenitor cell concentrations in marrow aspiration compared to traditional needles. It further adds that the device overcomes the limitations of traditional needles that restrict the amount of peripheral blood that would otherwise have been aspirated by forcing aspiration flow through side ports rather than from an open cannula. This setup has been a major issue with traditional needles and often led to the extraction of excessive amounts of bone marrow as well as impure marrow.
“Cellgenic plans with this new device to position itself as a leader in the development and manufacture of single-use medical devices for a number of medical specialties, we have developed a new bone marrow aspiration and biopsy needle that is manual, sterile and disposable, allowing precise procedures to be performed” said Benito Novas C.E.O of Global Stem Cells group
The new system offers the facility for doctors to reposition the needle more precisely at different access points. Precision is vital when trying to access bone marrow from specific sections of the bone.
According to Benito Novas, CEO of Global Stem Cells Group, the product will be launched at a press conference this September in Istanbul, Turkey within the framework of the World Congress of Regenerative Medicine. Additionally, it will be available at retail for doctors and distributors worldwide from October 2022
Buyers will undergo an orientation to use the new kit. It is easy to work with and many are expected to start using it as soon as they purchase it. The stem cells group will offer all the necessary training and support for the doctors during training and thereafter to ensure that the medical practitioners enjoy the full benefits of the device.
Global Stem Cells Group has been on the frontline in offering quality devices for stem cell procedures. It aims to make procedures as simple, risk-free, and efficient as possible for the maximum benefit of patients.
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
- Published in News
A federal judge recently ruled in favor of a regenerative medicine clinic against the FDA
The FDA brought the lawsuit against Cell Surgical Network Clinic in 2018 in an attempt to assert regulatory authority over stem cell therapies. The agency argued that a physician’s use of his patient’s own stem cells as part of the medical treatment provided to the patient was equivalent to manufacturing a biological drug product and therefore subject to regulation by the FDA.
The court rejected this argument on Tuesday, ruling that the surgical procedure does not create a new prescription drug. The court wrote: “The adipose tissue Defendants remove from patients clearly consists of human cells. And whatever is injected back into patients as part of Defendants’ SVF Surgical Procedure and Expanded MSC Surgical Procedure certainly contains such cells.”
This news opens up the possibilities and sets an important precedent for clinics in the United States to use autologous cellular treatments derived from adipose tissue, giving patients the right to use their own tissue to enhance regenerative processes and fight disease.
“We appreciate the Court’s clear and unequivocal ruling, which affirms what we have been saying for 12 years: that our innovative surgical approach to personal cell therapy is safe and legal,” said Dr. Elliott Lander, co-founder of CSCTC. “With this victory behind us, we look forward to refocusing our energy on our practice and leveraging life-changing stem cell treatments to support physicians and benefit patients across the country.”
As science advances, it’s inevitable that there will be more diverse forms of treatment with human stem cells. Whether the FDA gets on board and expands its rules about what is and is not legal is another question.
Unfortunately, much of what the FDA does falls into the category of politics. It’s usually unwise to make a decision about a particular kind of therapy or medical treatment based on whether it’s technically, currently legal.
It’s helpful to recall that many treatments that are fully legal began as experimental procedures that were not legally offered to the public but only took place in controlled research environments.
The good news is that stem cell therapy continues to make rapid advances on several different fronts, primarily those related to joint pain and associated discomfort. Athletes have made good use of the treatment and were, in fact, among the first major wave of clients for the technique when it was still brand new. After that, word spread about the effectiveness of stem cell treatment as more and more people turned to it as an alternative to surgery and prescription medication.
- Published in News
